← Open Payments lookup

ASHLEY HAGEMAN: Open Payments

NPI 1992077788 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,098 in 36 payments from 10 companies in 2025. Trend: 2023 $1,009 · 2024 $820 · 2025 $2,098

Food & beverage: $2,098
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.5$481
Teva Pharmaceuticals USA, Inc.8$342
Otsuka America Pharmaceutical, Inc.7$327
Neurocrine BioSciences, Inc.5$299
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$266
Alkermes, Inc.3$222
Janssen Pharmaceuticals, Inc1$81
Luye Pharma (USA) Ltd.2$43
Abbott Laboratories1$21
Lundbeck LLC1$15

Products named: COBENFY, UZEDY, INGREZZA, CAPLYTA, ABILIFY MAINTENA, LYBALVI, ARISTADA, ABILIFY ASIMTUFII.

Industry payments across NC — which companies pay providers there.